Copyright © 2025 Shenyang Dasan Pharmaceutical Technology Co., Ltd.
Home

News

Distinguish Title Data
Industry These 78 drugs and 4 types of high-value consumables are calculated separately under the DRG points system. 2022-11-11
Industry 15-Province Alliance Procurement Targets Off-Patent Drugs Not Passing Consistency Evaluation: Injectables Are the Focus! 2022-11-04
Industry 19 Blockbuster Drugs with Over $1 Billion in Sales See First Generics on the Way, with Chia Tai Tianqing and Others Entering the Fray 2022-10-21
Industry Implementation of the Seventh Round of National Centralized Procurement Continues: Hebei, Yunnan, Henan, Hainan 2022-10-14
Industry Domestic Original Innovative Drug Passes Medical Insurance Formal Review! Drug-Resistant Patients No Longer Need a "Drug God" 2022-09-23
Industry Turmoil Again in the 300 Billion Yuan Retail Market! 46 Varieties Explore New Opportunities, "Rx-to-OTC Switch" May Become the Future Trend 2022-09-16
Industry News Observation: Addressing the "High Medical Costs" Issue — More Quality Drugs Included in the Medical Insurance Reimbursement List 2022-09-09
Industry The Vaccine Hasn’t Changed: Why Has the 9-Valent HPV Vaccine Expanded Its Age Range to 9–45? 2022-09-02
Industry Zhejiang Centralized Procurement Reshapes 400 Million Yuan Market: 22 Varieties Head to the Test 2022-08-26
Company Dashan Pharmaceutical Autumn Team Building | Harvest Season, Joyful Journey 2022-08-23
Industry The Essential Medicines Shortage List is Here! Including National Centralized Procurement Suppliers, All to be Included in End-Point Monitoring 2022-08-12
Industry Levetiracetam’s centralized procurement shake-up: anti-epileptic drug sparks domestic ambition to catch up and surpass 2022-08-05